Successful research results on the safety of the coronavirus vaccine is still the first phase of its development. About it Federal News Agency virologist said Anatoly Altstein. Thus, the interlocutor of the FAN responded to the completion of tests in Russia of the world's first vaccine against coronavirus.
"Sechenovskiy University has successfully completed tests on volunteers of the world's first vaccine against coronavirus", - said the director of the Institute of Translational Medicine and Biotechnology Sechenovskogo University Vadim Tarasov.
As explained by the head of the Institute of Medical Parasitology, tropical and vector-borne diseases Sechenovskogo University Alexander Lukashev, at this stage it was necessary to show the safety of the vaccine for human health, which was done. Subjects admitted, that in the early days they felt a slight and short-term increase in body temperature. No other adverse effects were identified..
Lukashev specified, that all research participants were isolated for a long time and had practically no contact with the outside world even before the tests began, to rule out coronavirus infection.
Long-term isolation had an impact on the psychological state of volunteers and led to increased conflict situations among the two groups. Psychologists joined the work with volunteers, to relieve emotional tension.
celebrated, that volunteers will be discharged 15 and 20 July, then their condition will be monitored, to evaluate, how their immunity behaves. Lukashev also noted, that a further vaccine development plan will be determined by the developer.
Doctor of Medical Sciences Anatoly Altstein in an interview with FAN explained, that successful vaccine safety tests are very “good data”.
"Expect, that in the future volunteers will have some complications from her, not necessary. This type of vaccine has already been tested in humans., and they’re safe enough. ”, - said Altstein.
Nevertheless, the interlocutor of the FAN believes, that this is only the first part of the test, and therefore it’s too early to talk about vaccine readiness in general.
"These people have not yet received the last injection, and there should be two. After that you need some time, so that the serum is carefully examined for antibodies. When we will be informed, that such a percent of people have neutralizing antibodies, then we will talk about the end of the first phase of vaccine trials. Following this, the second and third phases will go., where more people will need to be vaccinated with the drug. In the second stage, likely, volunteers will take part ", - he noted.
As the virologist specifies, studies on vaccine efficacy usually last long enough.
“This phase can already be prepared, because for, to get vaccine efficacy data, thousands of people should be vaccinated in conditions, where is the epidemic going. Such studies may begin in late August or as early as September.. Moscow, for example, now not a very favorable city in terms of incidence. It is not excluded, that it will become the venue for such tests, - Altstein explains. - Regarding future categories of people, who will get the vaccine first, the, likely, it will be doctors. The drug will be offered to older people a little later. ".
Earlier, the Ministry of Defense of the Russian Federation reported good health of volunteers, who agreed to participate in a coronavirus vaccine test. In the department stressed, that they have not registered any serious adverse events.
World Health Organization (TRAIN) already interested in Russian coronavirus vaccine. WHO Senior Researcher Sumia Swaminathan hopes, that Russia is also interested in cooperation.
Head of the Ministry of Health of the Russian Federation Mikhail Murashko He stated, that three to four coronavirus vaccines are being developed in Russia. Minister noted, that drug testing is proceeding normally.
Author: Denis Stories
